Pneumococcal meningitis by an unusual serotype: a case report
DOI:
https://doi.org/10.18203/2349-3291.ijcp20253789Keywords:
Pneumococcal meningitis, Epidemiology, Eerotype, VaccinesAbstract
With the evolution of the vaccination and antimicrobian pressure, there has been changes in the Streptococcus pneumoniae serotypes becoming more frequent the ones not included in the vaccines. Herein this report presents a clinical case of a 11-month-old boy with meningitis due to Streptococcus pneumoniae serotype 24F. This serotype is not included in the vaccines available in Portugal. Therefore, we present this clinical case to explore and understand the changes of bacterial epidemiology.
Metrics
References
Nakamura T, Cohen AL, Schwartz S, Mwenda JM, Weldegebriel G, Biey JNM, et al. The global landscape of pediatric bacterial meningitis data reported to the World Health Organization–coordinated Invasive Bacterial Vaccine-Preventable Disease Surveillance Network, 2014–2019. J Infect Dis. 2021;224:S161-73.
GBD 2019 Meningitis Collaborators. Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2023;22(8):685-711. DOI: https://doi.org/10.1016/S1474-4422(23)00195-3
Pormohammad A, Ghorbani S, Khatami A, Nasiri MJ, Azimi T, Alborzi A, et al. Global study of viral meningitis: a systematic review and meta-analysis. J Pediatr Rev. 2022;10(2):101-12.
Jackson C, Török ME. Epidemiology and clinical outcomes of bacterial meningitis in children and adults in low- and middle-income countries. Curr Trop Med Rep. 2024;11(1):8-17. DOI: https://doi.org/10.1007/s40475-024-00316-0
Brooke P, Patel A, Agrawal S. Pneumococcal meningitis in children. Paediatr Child Health. 2023;33(5):e117-8. DOI: https://doi.org/10.1016/j.paed.2023.07.001
Yang Y, Knoll MD, Herbert C, Bennett JC, Feikin DR, Garcia Quesada M, et al. Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE project. J Infect. 2025;90(3):190-9. DOI: https://doi.org/10.1016/j.jinf.2025.106426
Cui YA, Patel H, O'Neil WM, Li S, Saddier P. Pneumococcal serotype distribution: A snapshot of recent data in pediatric and adult populations around the world. Hum Vaccin Immunother. 2017;13(6):1229-41. DOI: https://doi.org/10.1080/21645515.2016.1277300
Direção-Geral da Saúde. Norma 008/2005 - Programa Nacional de Vacinação. Introdução da vacina conjugada de 13 valências contra infeções por Streptococcus pneumoniae (Pn13). Lisboa; DGS: 2015.
Candeias C, Almeida ST, Paulo AC, Simões AS, Ferreira B, Cruz AR, et al. Streptococcus pneumoniae carriage, serotypes, genotypes, and antimicrobial resistance trends among children in Portugal, after introduction of PCV13 in National Immunization Program: A cross-sectional study. Vaccine. 2024;42(22):126219. DOI: https://doi.org/10.1016/j.vaccine.2024.126219
Aguiar SI, Brito MJ, Horácio AN, Lopes JP, Ramirez M, Melo-Cristino J; et al. Decreasing incidence and changes in serotype distribution of invasive pneumococcal disease in persons aged under 18 years since introduction of 10-valent and 13-valent conjugate vaccines in Portugal, July 2008 to June 2012. Euro Surveill. 2014;19(12):20750. DOI: https://doi.org/10.2807/1560-7917.ES2014.19.12.20750
Candeias C, Félix S, Handem S, de Lencastre H, Sá-Leão R. Clonal changes in the pneumococcal population carried by Portuguese children during six years of private use of the 13-valent pneumococcal conjugate vaccine: the relative contribution of clonal expansion, clonal emergence, and capsular switch events. Microbiol Spectr. 2023;11(2):e02909-22. DOI: https://doi.org/10.1128/spectrum.02909-22
Latasa Zamalloa P, Sanz Moreno JC, Ordobás Gavín M, Barranco Ordoñez MD, Insúa Marisquerena E, Gil de Miguel Á, et al. Trends of invasive pneumococcal disease and its serotypes in the Autonomous Community of Madrid. Enferm Infecc Microbiol Clin (Engl Ed). 2018;36(10):612-20. DOI: https://doi.org/10.1016/j.eimce.2018.07.007
Sanz JC, de Miguel S, Ordobás M, García Comas L. Streptococcus pneumoniae serotypes with meningeal tropism in cases of invasive pneumococcal disease. Community of Madrid, 2007–2018. Enferm Infecc Microbiol Clin (Engl Ed). 2020;38(8):371-4. DOI: https://doi.org/10.1016/j.eimce.2019.11.004
Reslan L, Finianos M, Bitar I, Moumneh MB, Araj GF, Zaghlout A, et al. The Emergence of Invasive Streptococcus pneumoniae Serotype 24F in Lebanon: Complete Genome Sequencing Reveals High Virulence and Antimicrobial Resistance Characteristics. Front Microbiol. 2021;12:637813. DOI: https://doi.org/10.3389/fmicb.2021.637813
Merck & Co., Inc. European Commission Approves Merck’s CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults. Rahway, NJ: Merck. 2025. Available at: https://www.merck.com/news/merck-receives-positive-eu-chmp-opinion-for-capvaxive-pneumococcal-21-valent-conjugate-vaccine-for-pneumococcal-vaccination-in-adults/. Accessed on 230 August 2025.
Downloads
Published
How to Cite
Issue
Section
